Tatsuhiro Masaoka
3PUBLICATIONS
4CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (3)
Sort by Publication Date:
|Jan 28, 2026
Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan-Amoxicillin-Sitafloxacin/Rifabutin Regimens.Hideki Mori, Yoshimasa Saito, Hiroko Ando
|Jun 01, 2022
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.Kazumi Inokuchi, Hideki Mori, Juntaro Matsuzaki
Pageof 1